Nuzenio

Therapeutics Secures

Therapeutics Secures news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 21 latest news signals 15 publisher sources 100/100 entity strength

Latest news

ReCode Therapeutics Secures Cystic Fibrosis Foundation Funding And Names Heather Clark CEO - Pulse 2.0Pulse 2.0 · Fri, 07 Aug 2026 03:12:22 GMT CytomX Therapeutics secures $37M from Regeneron amid Q2 revenue miss - scanx.tradescanx.trade · Fri, 07 Aug 2026 02:21:26 GMT Opal Therapeutics Secures $1.25 Million NSF Award To Expand Uterine Organoid Platform - Pulse 2.0Pulse 2.0 · Thu, 06 Aug 2026 14:16:15 GMT Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery - Business WireBusiness Wire · Thu, 06 Aug 2026 10:30:00 GMT Expedition Therapeutics Secures $115M Series B for COPD Therapy - DealroomDealroom · Wed, 05 Aug 2026 16:57:15 GMT Vivos Therapeutics Secures New U.S. Patent Expanding Protection for Vivos CARE Technology - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 14:48:48 GMT Mironid Secures $46m To Advance Rare Disease Therapeutics - eurekamagazine.co.ukeurekamagazine.co.uk · Wed, 05 Aug 2026 13:37:33 GMT NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:55:00 GMT

Timeline

Fri, 07 Aug 2026 03:12:22 GMTReCode Therapeutics Secures Cystic Fibrosis Foundation Funding And Names Heather Clark CEO - Pulse 2.0

Fri, 07 Aug 2026 02:21:26 GMTCytomX Therapeutics secures $37M from Regeneron amid Q2 revenue miss - scanx.trade

Thu, 06 Aug 2026 14:16:15 GMTOpal Therapeutics Secures $1.25 Million NSF Award To Expand Uterine Organoid Platform - Pulse 2.0

Thu, 06 Aug 2026 10:30:00 GMTOpal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery - Business Wire

Wed, 05 Aug 2026 16:57:15 GMTExpedition Therapeutics Secures $115M Series B for COPD Therapy - Dealroom

Wed, 05 Aug 2026 14:48:48 GMTVivos Therapeutics Secures New U.S. Patent Expanding Protection for Vivos CARE Technology - Yahoo Finance

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Pulse8 live mentions Secures6 live mentions Therapeutics5 live mentions CMP4 live mentions Opal Therapeutics Secures3 live mentions Expedition Therapeutics Secures3 live mentions Medical Device Network3 live mentions Processa Pharmaceuticals Acquires3 live mentions Vidya Therapeutics3 live mentions ReCode Therapeutics Secures2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Therapeutics Secures.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

15 distinct publisher/source names are currently connected to this entity page.